v3.25.1
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 7,154 $ 1,173
Accounts receivable 43
Prepaid expenses 328 168
Other current assets 303 24
Deferred offering costs 101
Total current assets 7,828 1,466
Right-of-use operating asset 278
Property and equipment, net 12
Total assets 8,118 1,466
Current liabilities:    
Accounts payable 586 561
Accrued expenses 1,323 614
Total current liabilities 1,909 1,175
Common stock warrant liability 1,519 3,291
Operating lease liability, net of current portion 212
Total liabilities 3,640 4,466
Commitments and contingencies (Note 6)
Convertible preferred stock and stockholders’ equity (deficit):    
Convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized as of December 31, 2024 and 2023, respectively; zero shares issued and outstanding at December 31, 2024 and 2023, respectively
Common stock, $0.0001 par value, 250,000,000 shares authorized at December 31, 2024, and 2023, respectively; 24,034,672 and 10,693,580 shares issued and outstanding as of December 31, 2024, and 2023, respectively 2 1
Additional paid-in capital 54,695 38,404
Accumulated other comprehensive income
Accumulated deficit (50,219) (41,405)
Total convertible preferred stock and stockholders’ (deficit) equity 4,478 (3,000)
Total liabilities, convertible preferred stock and stockholders’ equity (deficit) $ 8,118 $ 1,466

Source

PDF HTML 10-K Filing
ZIP XLS XBRL